DifGen Pharmaceuticals' single injection treatment for advanced breast cancer cleared for clinical development

AbelZeta's C-CAR168 registrational Phase II trial in refractory Lupus Nephritis granted FDA clearance

AcuCort secures renewed FDA fee waiver ahead of planned NDA submission

Yarrow Bioscience completes VYNE merger and begins Phase 2 trial of YB-101

NewAmsterdam Pharma and Menarini Group report positive CHMP opinion for obicetrapib monotherapy and obicetrapib/ezetimibe combination

Asymchem's DH2 site completes first FDA inspection for continuous manufacturing of API

Par Health launches generic version of Janumet XR tablets in US

FDA approves Furoscix ReadyFlow for at-home treatment of edema

CHMP backs Gilead's Trodelvy-Keytruda combination for first-line metastatic triple-negative breast cancer

FDA grants Fast Track designation to Lundbeck's narcolepsy candidate Lu AH69593

Scancell and Neuphoria agree merger

Eurofins Viracor introduces BKV inSIGHT T-cell immunity panel for BK virus immune monitoring in kidney transplant patients

GSK's Jideytro (zidesamtinib) gains US approval for previously treated ROS1-positive NSCLC

Hugel Aesthetics expands US presence

European Commission expands Crysvita approval to infants with XLH